Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes
Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase
- Cora Weigert,
- Karsten Klopfer,
- Christiana Kausch,
- Katrin Brodbeck,
- Michael Stumvoll,
- Hans U. Häring and
- Erwin D. Schleicher
- From the Department of Internal Medicine, Division of Endocrinology, Metabolism and Pathobiochemistry, University of Tübingen, Tübingen, Germany
Abstract
The nutrient sensing capacity of the hexosamine biosynthetic pathway (HBP) has been implicated in the development of insulin resistance of skeletal muscle. To study the molecular mechanism of the free fatty acid (FFA)-induced activation of the HBP myotubes obtained from muscle biopsies of metabolically characterized, subjects were stimulated with different fatty acids for 20 h. Incubation with the saturated fatty acids palmitate and stearate (0.5 mmol/l) resulted in a three- to fourfold increase in mRNA expression of glutamine:fructose-6-phosphate aminotransferase (GFAT), the key and rate-limiting enzyme of the hexosamine pathway. Unsaturated fatty acids or 30 mmol/l glucose had little or no effect. Palmitate increased the amount of GFAT protein nearly two-fold, and subsequently, the concentration of UDP-N-acetylglucosamine, the end product of the HBP, was 1.3-fold enhanced in the palmitate-stimulated myotubes. The nonmetabolized fatty acid bromopalmitate had no effect. The DNA binding activity of the transcription factor Sp1, a target downstream of the HBP, was increased by palmitate and completely lost after enzymatic removal of O-GlcNAc. No correlation was found between the palmitate-induced increase in GFAT protein and the insulin resistance in the respective subjects. The findings reveal a new mechanism for how FFAs induce the activation of the HBP.
Footnotes
-
Address correspondence and reprint requests to Dr. Erwin D. Schleicher, Department of Internal Medicine, Division of Endocrinology, Metabolism and Pathobiochemistry, University of Tübingen, Otfried-Müller-Straße 10, D-72076 Tübingen, Germany. Email: enschlei{at}med.uni-tuebingen.de.
Received for publication 2 July 2002 and accepted in revised form 17 December 2002.
FBS, fetal bovine serum; FFA, free fatty acid; GlcN-6-P, glucosamine-6-phosphate; GFAT, glutamine:fructose-6-phosphate amidotransferase; GIR, glucose infusion rate; HBP, hexosamine biosynthetic pathway; LBM, lean body mass; Oct-1, octamer binding protein; Sp1, stimulating protein 1; PDH, pyruvate dehydrogenase; PFK, phosphofructokinase; UDP-GlcNAc, uridine-5′-diphosphate-N-acetylglucosamine.
- DIABETES














